INSTITUTIONAL PLACEMENT & SPP
BluGlass Limited (the Company) is pleased to announce that it has raised AUD $9.2 million from institutional, professional and sophisticated investors at AUD$0.37 per share (Issue Price) (Placement).
The Company is also pleased to announce that it will undertake a Share Purchase Plan under which eligible shareholders of the Company with addresses in Australia and New Zealand will be provided with an opportunity to subscribe for up to A$15,000 worth of new fully paid ordinary shares at the same Issue Price to raise up to approximately AUD$5,000,000 (SPP).
The funds raised under the Placement and SPP (after costs) are intended to be used to:
Acquire additional MOCVD equipment to build and demonstrate applications by retrofitting MOCVD equipment with RPCVD on commercial platforms;
Undertake a major facilities upgrade to expand current infrastructure to assist in the acceleration of RPCVD development; and
To strengthen the Company’s balance sheet to exploit market opportunities and help fund the planned increase in activity.
The Issue Price of AUD$0.37 per share under the Placement and the SPP represents an 8.6% discount to the Company’s closing share price on 16 May 2018 and an 11.4% discount to the Company’s 5-day volume weighed average price ending on 16 May 2018 (VWAP).
The Company appointed Wilsons Corporate Finance Limited (ABN 65 057 547 323) and Stifel Nicolaus Europe Limited (together, the Managers) to act as Joint Lead Managers and Bookrunners to the Placement.
BluGlass Managing Director Giles Bourne said, “We are very pleased to see the significant cornerstone support from global institutional funds. These funds have invested alongside domestic institutional and retail investors. Proceeds from the placement will enable BluGlass to expedite its technical and commercial goals with our collaborative partners and deliver commercial outcomes for our proprietary RPCVD technology.’’